Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma

Clinical trial NCT00742963 · COMPLETED

Trial details

NCT number: NCT00742963
Sponsor: ImmunoGenesis
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Soft Tissue Sarcoma

Start date: 2008-08-01
Primary completion: 2013-07-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.